CLINICAL_TRIALS
research
· 2019-11-22
Clinical Trial Update: Estrogen and the Urogenital Microbiome in GSM [Phase 4]
Summary
Phase 4 clinical trial updating on estrogen effects and the urogenital microbiome in menopause.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Oregon Health and Science University | Conditions: Menopause | Phase 4 | Status: COMPLETED